| scholarly article | Q13442814 |
| P50 | author | Gary S Stein | Q88625567 |
| Thomas P Ahern | Q42581653 | ||
| P2093 | author name string | Janet L Stein | |
| Jane B Lian | |||
| Marie E Wood | |||
| Nicholas H Farina | |||
| Melissa E Cuke | |||
| P2860 | cites work | Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. | Q54456800 |
| Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence–European Prospective Investigation Into Cancer and Nutrition Cohort | Q56836342 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ. | Q64896635 | ||
| Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
| Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study | Q72241677 | ||
| Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction | Q72752023 | ||
| Limitations of the Gail model in the specialized breast cancer risk assessment clinic | Q77664178 | ||
| Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers | Q78198665 | ||
| A prospective study of breast cancer risk using routine mammographic breast density measurements | Q80123666 | ||
| Prospective breast cancer risk prediction model for women undergoing screening mammography | Q80216670 | ||
| Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? | Q81370089 | ||
| A role for common genomic variants in the assessment of familial breast cancer | Q85312916 | ||
| Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer | Q85907155 | ||
| MicroRNAs in cancer | Q86065522 | ||
| Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing | Q87912175 | ||
| Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications | Q88364975 | ||
| Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection | Q21134914 | ||
| Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers | Q21195201 | ||
| Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Genetic Misdiagnoses and the Potential for Health Disparities | Q26316693 | ||
| Gene-environment interaction and risk of breast cancer | Q26772236 | ||
| Current State of Circulating MicroRNAs as Cancer Biomarkers | Q26796328 | ||
| Systemic mirnas as potential biomarkers for malignancy | Q27004655 | ||
| Methodological challenges in utilizing miRNAs as circulating biomarkers | Q27027950 | ||
| Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society | Q27347760 | ||
| microRNA Therapeutics in Cancer - An Emerging Concept | Q28068855 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
| American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography | Q28295438 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| Non-coding RNAs: regulators of disease | Q29618040 | ||
| The microRNA spectrum in 12 body fluids | Q29618068 | ||
| Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. | Q30238753 | ||
| Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk | Q30311964 | ||
| Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women | Q30501421 | ||
| Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention | Q32133889 | ||
| Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance | Q33739374 | ||
| A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer | Q33742015 | ||
| Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum | Q33824699 | ||
| Exosome: from internal vesicle of the multivesicular body to intercellular signaling device | Q34030873 | ||
| Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia | Q34049245 | ||
| Genome-wide association study identifies five new breast cancer susceptibility loci | Q34114293 | ||
| Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation | Q34129784 | ||
| Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer | Q34412367 | ||
| Understanding mathematical models for breast cancer risk assessment and counseling | Q34419051 | ||
| Frequency and spectrum of cancers in the Peutz-Jeghers syndrome | Q34567595 | ||
| Risk estimation for breast cancer development; a clinical perspective | Q34646517 | ||
| Identification and evaluation of plasma microRNAs for early detection of colorectal cancer | Q34729935 | ||
| Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer | Q34736112 | ||
| Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. | Q35000324 | ||
| A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2. | Q35082982 | ||
| Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium | Q35166701 | ||
| Genetic analysis of breast cancer in the cancer and steroid hormone study | Q35196511 | ||
| Extracellular microRNA: a new source of biomarkers | Q35417685 | ||
| Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme | Q35441054 | ||
| Lifetime cancer risks in individuals with germline PTEN mutations. | Q35681689 | ||
| Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
| Hereditary cancer predisposition syndromes | Q36002146 | ||
| Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia | Q36070308 | ||
| Cross talk between microRNA and coding cancer genes. | Q36073979 | ||
| Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer | Q36090967 | ||
| The contributions of breast density and common genetic variation to breast cancer risk | Q36137764 | ||
| MicroRNAs in body fluids--the mix of hormones and biomarkers | Q36176435 | ||
| Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention | Q36255311 | ||
| Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort | Q36336239 | ||
| Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement | Q36393193 | ||
| Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry | Q36619329 | ||
| microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR. | Q36647044 | ||
| miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells | Q36759835 | ||
| Genome-wide association analysis identifies three new breast cancer susceptibility loci | Q36842233 | ||
| Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q36858843 | ||
| Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
| Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older | Q37353842 | ||
| Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab | Q37410693 | ||
| Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling | Q37699255 | ||
| Standardizing analysis of circulating microRNA: clinical and biological relevance | Q37712040 | ||
| Preventive therapy for breast cancer: a consensus statement | Q37858249 | ||
| A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance | Q37950847 | ||
| Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation | Q38173683 | ||
| Serum Tumor Markers in Stage I-II Breast Cancer | Q38633235 | ||
| Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 | ||
| The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer | Q38721385 | ||
| MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction | Q39029051 | ||
| Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women | Q39076835 | ||
| Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. | Q39217323 | ||
| Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. | Q39263736 | ||
| Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. | Q39530261 | ||
| Projecting individualized absolute invasive breast cancer risk in African American women | Q40149673 | ||
| A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer | Q40420399 | ||
| Breast cancer risk prediction using a clinical risk model and polygenic risk score | Q40605693 | ||
| Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis | Q40965602 | ||
| Challenges in using circulating miRNAs as cancer biomarkers | Q41072824 | ||
| Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy | Q41954466 | ||
| Breast cancer risk and measured mammographic density. | Q43696589 | ||
| Breast density and breast cancer risk factors in a high-risk population. | Q44310137 | ||
| A longitudinal investigation of mammographic density: the multiethnic cohort | Q45202542 | ||
| Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families | Q45243999 | ||
| Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population | Q45285503 | ||
| Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. | Q45990033 | ||
| Mammographic density and breast cancer in three ethnic groups | Q46311063 | ||
| The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont | Q47233230 | ||
| Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations | Q47645440 | ||
| Development of a predictive miRNA signature for breast cancer risk among high-risk women | Q47724615 | ||
| Validation studies for models projecting the risk of invasive and total breast cancer incidence. | Q50651945 | ||
| Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. | Q51535040 | ||
| Searching for candidate microRNA biomarkers in detection of breast cancer: a meta-analysis. | Q51757659 | ||
| A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
| A plasma microRNA panel for early detection of colorectal cancer. | Q54270072 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1305-1316 | |
| P577 | publication date | 2019-02-01 | |
| P1433 | published in | Aging | Q2845875 |
| P1476 | title | Towards a more precise and individualized assessment of breast cancer risk | |
| P478 | volume | 11 |
Search more.